Search

Patients with metastatic melanoma have a poorer prognosis. Prion protein (PrP) in melanoma is known to play an important role in cancer cell migration and invasion by interacting with filamin A (FLNa), a cytolinker protein. To investigate if PrP may contribute to cancer cell mobility independent of its binding to FLNa, we knocked out PRNP in M2 melanoma cell, which lacked FLNa expression. We found that deletion of PRNP in M2 significantly reduced its motility. When PRNP was deleted, the level of Akt was decreased. As a consequence, phosphorylation of small heat shock protein (hsp27) was also reduced, which resulted in polymerization of F-actin rendering the cells less migratory. Accordingly, when PrP was re-expressed in PRNP null M2 cells, the mobility of the recurred cells was rescued, so were the expression levels of Akt and phosphorylated hsp27, resulting in a decrease in the polymerization of F-actin. These results revealed that PrP can play a FLNa independent role in cytoskeletal organization and tumor cell migration by modulating Akt-hsp27-F-actin axis. • Filamin A (FLNa) independent cell migration has not been thoroughly studied. • Prion protein (PrP) modulates actin polymerization and mediates M2 melanoma cell migration independent of FLNa. • Expression of PrP stabilizes protein kinase B (Akt), enhances interaction between Akt and heat shock protein 27 (hsp27). • Akt phosphorylates hsp27 to reduce polymerization of F-actin, which in turn to enhance cancer cell migration. [ABSTRACT FROM AUTHOR]